1. Home
  2. RAIL vs HUMA Comparison

RAIL vs HUMA Comparison

Compare RAIL & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FreightCar America Inc.

RAIL

FreightCar America Inc.

HOLD

Current Price

$7.84

Market Cap

149.9M

Sector

Industrials

ML Signal

HOLD

Logo Humacyte Inc.

HUMA

Humacyte Inc.

HOLD

Current Price

$0.89

Market Cap

155.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RAIL
HUMA
Founded
1901
2004
Country
United States
United States
Employees
N/A
184
Industry
Railroads
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
149.9M
155.4M
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
RAIL
HUMA
Price
$7.84
$0.89
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$6.19
AVG Volume (30 Days)
139.3K
4.2M
Earning Date
05-04-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
134.94
N/A
EPS
1.15
N/A
Revenue
$500,991,000.00
N/A
Revenue This Year
$6.54
$444.16
Revenue Next Year
$30.90
$248.39
P/E Ratio
$7.39
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.02
$0.55
52 Week High
$14.90
$2.93

Technical Indicators

Market Signals
Indicator
RAIL
HUMA
Relative Strength Index (RSI) 33.65 58.78
Support Level $7.78 $0.65
Resistance Level $10.09 $1.27
Average True Range (ATR) 0.46 0.07
MACD -0.04 0.03
Stochastic Oscillator 21.05 76.31

Price Performance

Historical Comparison
RAIL
HUMA

About RAIL FreightCar America Inc.

FreightCar America Inc is a diversified manufacturer and supplier of railcars and railcar components. It designs and manufactures a variety of railcar types for transportation of bulk commodities and containerized freight products in North America. The company also provides railcar rebody and repair services, railcar conversion services, and supplies railcar parts. The company has two segments: Manufacturing and Aftermarket. The majority of the company's revenue is derived from the Manufacturing segment, which includes new railcar manufacturing, used railcar sales, and various conversions and rebodies. Geographically, it generates the maximum revenue from the United States.

About HUMA Humacyte Inc.

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: